Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Neoplasm Metastasis 9Colorectal Neoplasms 8Rectal Neoplasms 7Liver Neoplasms 7Carcinoma, Hepatocellular 7Colonic Neoplasms 6Rhabdomyosarcoma 4Hepatoblastoma 4Wilms Tumor 3Sarcoma, Ewing 3Sarcoma 3Rhabdoid Tumor 3Retinoblastoma 3Neuroblastoma 3Melanoma 3Medulloblastoma 3Central Nervous System Neoplasms 3Carcinoma, Renal Cell 3Uveal Melanoma 2Pancreatic Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Kidney Neoplasms 2Hyperthermia 2Carcinoma, Islet Cell 2Brain Neoplasms 2Astrocytoma 2Appendiceal Neoplasms 2Vipoma 1Testicular Neoplasms 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 17Cisplatin 12Oxaliplatin 10Cytoreduction Surgical Procedures 10Fluorouracil 9Paclitaxel 8Mitomycin 8Leucovorin 6Surgical Procedures, Operative 4Doxorubicin 3Observation 2Neoadjuvant Therapy 2Laparoscopy 2Indocyanine Green 2Docetaxel 2Control Groups 2Chemotherapy, Adjuvant 2Carboplatin 2Capecitabine 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2tremelimumab 1sodium thiosulfate 1pembrolizumab 1nilotinib 1lobaplatin 1irinotecan sucrosofate 1genexol-PM 1durvalumab 1dehydroftorafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peritoneal Neoplasms × Melphalan × Gastrointestinal × Clear all
NCT03073694 2023-06-09

Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis

University of Kansas Medical Center

Phase 2 Unknown
100 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡